Search

Search Constraints

You searched for: Author/Creator Huntington, Scott F.

Search Results

1. Association of provider experience and clinical outcomes in patients with myelodysplastic syndromes receiving hypomethylating agents. Issue 2 (28th January 2020)

2. Clinical effectiveness of DNA methyltransferase inhibitors and lenalidomide in older patients with refractory anemia with ring sideroblasts: a population-based study in the United States. Issue 10 (24th August 2021)

3. Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes. (21st September 2016)

4. Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United States. (November 2021)

5. Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United States. (October 2021)

6. Cost-effectiveness of azacitidine and ivosidenib in newly diagnosed older, intensive chemotherapy-ineligible patients with IDH1-mutant acute myeloid leukemia. Issue 2 (28th January 2023)

9. Cost‐effectiveness analysis of consolidation with brentuximab vedotin for high‐risk Hodgkin lymphoma after autologous stem cell transplantation. Issue 19 (22nd June 2017)

10. DTRMWXHS‐12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open‐label, multicenter, phase 1a/1b study. Issue 5 (7th March 2023)